Malayali Healthcare Pheno Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 1.38 M
as on 06-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 1.89 M
as on 06-12-2024
- Revenue -25.79%
(FY 2015)
- Profit 15.10%
(FY 2015)
- Ebitda 45.39%
(FY 2015)
- Net Worth -21.89%
(FY 2015)
- Total Assets 12.14%
(FY 2015)
About Malayali Healthcare Pheno
The Corporate was formerly known as Phenomenal Health Care (Malayali) Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.38 M.
The company currently has active open charges totaling ₹1.89 M.
Kavalakkat Raphael, Thomas Thomas, and Shamsheer Fakkir serve as directors at the Company.
- CIN/LLPIN
U85190MH2008PTC186988
- Company No.
186988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2008
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Malayali Healthcare Pheno?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kavalakkat Raphael  | Managing Director | 23-Sep-2008 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomas Thomas | Director | 23-Sep-2008 | Current |
| Shamsheer Fakkir | Director | 01-Jul-2012 | Current |
Financial Performance of Malayali Healthcare Pheno.
Malayali Healthcare Pheno Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 25.79% decrease. The company also saw a substantial improvement in profitability, with a 15.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Malayali Healthcare Pheno?
In 2015, Malayali Healthcare Pheno had a promoter holding of 29.11% and a public holding of 70.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Copporation Bank Creation Date: 31 May 2013 | ₹1.89 M | Open |
How Many Employees Work at Malayali Healthcare Pheno?
Malayali Healthcare Pheno has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malayali Healthcare Pheno, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malayali Healthcare Pheno's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
